Skip to contentL
LifeMD, Inc.
L
LFMDLifeMD, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$27.42M$27.42Mderived+112.6% vs Q4 2020 Net Income-$18.11M-$18.11MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LifeMD, Inc. · CIK 948320 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$21,849,254+150.0% Operating Incomederived-$13,664,677N/M Operating Cash Flowderived-$5,825,939N/M Free Cash Flowderived-$6,003,199— Margins · derivedGross margin79.7%+11.9 pt vs Q4 2020
Operating margin-49.8%+200.9 pt vs Q4 2020
Net margin-66.1%+184.1 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 7, 2022 · 66 d after period end